ACS nanoOct 23, 2026

Using mRNA Nanoparticles Delivered to the Gut for Whole-Body Vaccines and Metabolic Treatment

mRNA Technology Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated Oct 24, 2026

Abstract

Gastric administration of lipid nanoparticles (LNPs) achieved an order of magnitude greater pancreas delivery in rodents compared to intravenous administration.

Gastric delivery of LNPs improved localization to multiple tissue types, including the pancreas and gastrointestinal tract.
Gastric dosing of glucagon-like peptide-1 mRNA led to enhanced blood glucose regulation in mice compared to controls.
Buccal administration of LNPs effectively targeted local and lymphatic tissues.
Ovalbumin mRNA delivered via gastric administration produced similar immunoglobulin G blood titers as intramuscular delivery.
GI administration of LNPs may broaden therapeutic possibilities for local and systemic nucleic acid delivery.

Simplified

Lipid nanoparticles (LNPs) administered parenterally often show poor localization to multiple tissue types, including the pancreas and gastrointestinal (GI) tract. Furthermore, patients typically prefer orally administered drugs to those that are given parenterally. We therefore investigated whether GI LNP administration to buccal, gastric, small intestinal, colonic, and rectal submucosal tissues could simultaneously circumvent parenteral administration while enhancing LNP delivery to previously inaccessible locations. We found that, in addition to local targeting, gastric LNP administration achieved an order of magnitude greater pancreas delivery in rodents than intravenous administration. Gastric dosing of glucagon-like peptide-1 mRNA also improved blood glucose regulation in mice compared with phosphate-buffered saline controls. Additionally, we found that buccal LNP administration targeted local and lymphatic tissues. Furthermore, dosing mice with ovalbumin mRNA resulted in equivalent immunoglobulin G blood titers to those of intramuscular delivery. These results suggest that GI administration can reprogram LNP biodistribution, expanding therapeutic opportunities for both local and systemic nucleic acid delivery.

Full Text

Full text is available at the source.

View Full Text ↗

Using mRNA Nanoparticles Delivered to the Gut for Whole-Body Vaccines and Metabolic Treatment

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the mrna technology brief